Alexander Ditchfield
Managing Director, Head of New York
ニューヨーク
Alexander Ditchfield is a Managing Director and Head of BDA’s New York office. Clients for whom he has advised on transactions include Aterian Investment Partners, CHS, CITIC Capital, Kerry, Littlejohn, On Semi, MacLean-Fogg, Molex, and Pfizer, among others.
Prior to moving to New York in 2016, he worked in BDA’s Shanghai and Hong Kong offices for seven years. He speaks Mandarin and English.
Recent transactions
acquired majority stake in
2024
ヘルスケア
received investment from
2023
インダストリアルズ
a portfolio company of
has been sold to
2023
インダストリアルズ
divested Niigata fab to
Sangyo Sosei and Fukuoka Capital
2022
インダストリアルズ
acquired by
a portfolio company of
2022
ケミカル
has been acquired by
2022
テクノロジー
divested ASG Print to
and
2021
インダストリアルズ
has been acquired by
2021
ケミカル
divested China phenolic resins plant to
2021
ケミカル
divested to
a portfolio company of
2020
ケミカル
Presswerk Krefeld a portfolio company of
has been acquired by
2017
インダストリアルズ
raised equity capital and new Asian partnerships
2016
ケミカル
CHS Ningbo Protein Foods a subsidiary of CHS has been acquired by
Shandong Wonderful
2016
コンシューマー
a portfolio company of
has been acquired by
2016
インダストリアルズ
divested
to
2014
インダストリアルズ
divested
to American Tire Distributors
2014
インダストリアルズ
divested KDM to Superior Capital Partners / Nelson-Miller
2012
インダストリアルズ